Last 7 days
0.8%
Last 30 days
8.1%
Last 90 days
7.7%
Trailing 12 Months
2.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-19 | MCNABB FREDERICK WILLIAM III | acquired | - | - | 23.00 | - |
2023-09-19 | Gil Kristen | acquired | - | - | 2.00 | - |
2023-09-19 | McSweeney Erin | acquired | - | - | 26.418 | evp chief people officer |
2023-09-19 | MONTGOMERY RICE VALERIE MD | acquired | - | - | 18.00 | - |
2023-09-19 | Noseworthy John H | acquired | - | - | 18.00 | - |
2023-09-19 | REX JOHN F | acquired | - | - | 71.646 | evp chief financial officer |
2023-09-19 | ROOS THOMAS E | acquired | - | - | 20.719 | chief accounting officer |
2023-09-19 | THOMPSON BRIAN R | acquired | - | - | 43.829 | ceo, unitedhealthcare |
2023-09-19 | WITTY ANDREW | acquired | - | - | 100 | ceo, uhg |
2023-09-19 | Bondy Rupert M | acquired | - | - | 15.868 | evp & chief legal officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-26 | BROOKFIELD Corp /ON/ | added | 530 | 14,822,500 | 17,561,600 | 0.07% |
2023-09-26 | M Holdings Securities, Inc. | reduced | -70.19 | -1,105,000 | 481,000 | 0.10% |
2023-09-26 | DecisionPoint Financial, LLC | unchanged | - | 459 | 27,397 | 0.01% |
2023-09-21 | Baystate Wealth Management LLC | added | 0.52 | 14,370 | 651,991 | 0.05% |
2023-09-21 | Jefferies Group LLC | added | 235 | 29,793,900 | 42,775,900 | 0.36% |
2023-09-21 | Halpern Financial, Inc. | added | 27.00 | 13,782 | 61,041 | 0.02% |
2023-09-20 | BARCLAYS PLC | added | 135 | 978,517,000 | 1,679,400,000 | 1.06% |
2023-09-18 | CAPE ANN SAVINGS BANK | added | 1.25 | 67,535 | 2,339,280 | 1.56% |
2023-09-18 | WASHINGTON CAPITAL MANAGEMENT, INC | reduced | -20.98 | -241,035 | 986,754 | 0.84% |
2023-09-15 | CJM Wealth Advisers, Ltd. | unchanged | - | 4,863 | 290,307 | 0.15% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.00% | 84,052,380 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.0% | 74,418,906 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 8.44% | 79,483,862 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.4% | 69,275,884 | SC 13G/A | |
Feb 16, 2021 | capital world investors | 3.7% | 35,185,176 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.34% | 79,092,547 | SC 13G/A | |
Feb 08, 2021 | fmr llc | - | 0 | SC 13G/A | |
Feb 01, 2021 | blackrock inc. | 7.5% | 71,592,885 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 22, 2023 | 8-K/A | Current Report | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading | |
Sep 21, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 477.0B | 348.5B | 8.05% | 2.57% | 22.6 | 1.37 | 13.69% | 15.63% |
CI | 91.1B | 186.1B | 3.93% | 4.43% | 13.64 | 1.92 | 3.72% | 22.38% |
HUM | 65.7B | 98.7B | 6.76% | 1.35% | 23.41 | 0.71 | 10.45% | 7.48% |
CNC | 37.8B | 147.9B | 13.11% | -10.94% | 13.95 | 0.26 | 7.12% | 45.86% |
MID-CAP | ||||||||
HQY | 6.3B | 937.9M | 11.11% | 9.87% | 492.64 | 6.74 | 17.97% | 120.64% |
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
CRVL | 3.4B | 732.5M | -4.43% | 43.03% | 48.77 | 4.63 | 9.34% | 4.86% |
AMN | 3.2B | 4.4B | -3.42% | -20.15% | 10.06 | 0.73 | -16.06% | -30.43% |
PDCO | 2.9B | 6.5B | -1.39% | 25.34% | 13.37 | 0.44 | 1.83% | 10.70% |
SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -13.69% | 38.13% | -147.42 | 1.24 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -2.28% | -10.83% | 25.58 | 1.38 | 10.42% | 21.37% |
BKD | 713.4M | 3.0B | -11.86% | -11.24% | -6.92 | 0.24 | 11.66% | -12.20% |
23.4%
22.3%
15.2%
19.5%
31.9%
18.5%
0%
Y-axis is the maximum loss one would have experienced if UnitedHealth Group was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 3.7% | 348,515 | 335,944 | 324,162 | 315,118 | 306,561 | 297,550 | 287,597 | 279,321 | 272,099 | 262,916 | 257,141 | 252,575 | 247,811 | 246,268 | 242,155 | 239,671 | 235,876 | 231,367 | 226,247 | 219,891 | 213,657 |
Costs and Expenses | 3.8% | 318,019 | 306,373 | 295,727 | 288,033 | 281,226 | 273,369 | 263,627 | 257,375 | 251,214 | 238,768 | 234,736 | 228,592 | 223,465 | 226,419 | 222,470 | 220,584 | 217,213 | 213,244 | 208,903 | 203,067 | 197,335 |
S&GA Expenses | 4.2% | 52,106 | 50,006 | 47,782 | 46,045 | 45,107 | 43,757 | 42,579 | 42,821 | 42,270 | 41,912 | 41,704 | 39,491 | 38,277 | 36,691 | 35,193 | 34,595 | 34,114 | 34,085 | 34,074 | 33,191 | 32,099 |
EBITDA | -100.0% | - | 33,153 | 31,835 | 30,274 | 28,492 | 27,314 | 27,073 | 25,010 | 23,872 | 27,074 | 25,296 | 26,860 | 27,213 | 22,653 | 22,405 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.10* | 0.10* | 0.10* | 0.12* | 0.09* | 0.09* | 0.09* | 0.09* | 0.10* | 0.10* | 0.11* | 0.11* | 0.09* | 0.09* | - | - | - | - | - | - |
Interest Expenses | 15.0% | 2,774 | 2,413 | 2,092 | 1,847 | 1,753 | 1,696 | 1,660 | 1,630 | 1,603 | 1,623 | 1,663 | 1,699 | 1,753 | 1,741 | 1,704 | 1,641 | 1,545 | 1,471 | 1,400 | 1,334 | 1,275 |
Earnings Before Taxes | 2.1% | 27,722 | 27,158 | 26,343 | 25,238 | 23,582 | 22,485 | 22,310 | 20,316 | 19,282 | 22,525 | 20,742 | 22,284 | 22,593 | 18,108 | 17,981 | 17,446 | 17,118 | 16,652 | 15,944 | 15,490 | 15,047 |
EBT Margin | -100.0% | - | 0.08* | 0.08* | 0.08* | 0.10* | 0.08* | 0.08* | 0.07* | 0.07* | 0.09* | 0.08* | 0.09* | 0.09* | 0.07* | 0.07* | - | - | - | - | - | - |
Net Income | 2.0% | 21,108 | 20,704 | 20,120 | 19,430 | 18,254 | 17,450 | 17,285 | 15,426 | 14,512 | 16,883 | 15,403 | 16,732 | 17,098 | 13,754 | 13,839 | 13,338 | 12,988 | 12,617 | 11,986 | 12,563 | 11,860 |
Net Income Margin | -100.0% | - | 0.06* | 0.06* | 0.06* | 0.07* | 0.06* | 0.06* | 0.06* | 0.05* | 0.06* | 0.06* | 0.07* | 0.07* | 0.06* | 0.06* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 34,207 | 23,404 | 31,326 | 20,452 | 19,216 | 19,889 | 22,893 | 18,512 | 23,086 | 20,123 | 20,151 | 20,287 | 16,194 | 16,392 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -1.2% | 280,164 | 283,679 | 245,705 | 243,064 | 230,172 | 221,238 | 212,206 | 213,045 | 210,292 | 205,171 | 197,289 | 190,969 | 192,483 | 189,067 | 173,889 | 173,709 | 167,200 | 161,197 | 152,221 | 151,087 | 154,611 |
Current Assets | -4.3% | 89,869 | 93,895 | 69,069 | 82,937 | 68,356 | 69,029 | 61,758 | 61,610 | 58,916 | 59,508 | 53,718 | 54,821 | 58,918 | 58,807 | 42,634 | 43,541 | 42,038 | 42,815 | 38,692 | 38,754 | 46,634 |
Cash Equivalents | -0.2% | 41,813 | 41,913 | 23,365 | 38,845 | 24,612 | 25,482 | 21,375 | 21,085 | 19,832 | 19,955 | 16,921 | 17,550 | 22,327 | 21,569 | 10,985 | 12,363 | 13,745 | 12,407 | 10,866 | 10,263 | 18,368 |
Net PPE | 2.7% | 10,926 | 10,637 | 10,128 | 9,469 | 9,421 | 9,183 | 8,969 | 8,730 | 8,735 | 8,496 | 8,626 | 8,151 | 8,126 | 8,173 | 8,704 | 8,501 | 8,681 | 8,230 | 8,458 | 8,042 | 7,906 |
Goodwill | 1.3% | 101,669 | 100,406 | 93,352 | 83,904 | 84,159 | 77,548 | 75,795 | 75,435 | 75,827 | 72,162 | 71,337 | 68,088 | 67,872 | 65,302 | 65,659 | 65,205 | 62,000 | 59,379 | 58,910 | 58,703 | 56,271 |
Liabilities | -2.6% | 188,008 | 193,057 | 159,358 | 160,143 | 149,045 | 143,591 | 135,727 | 138,413 | 136,971 | 134,589 | 126,750 | 121,018 | 124,126 | 127,463 | 111,727 | 113,962 | 109,144 | 104,692 | 95,994 | 96,722 | 101,989 |
Current Liabilities | -3.0% | 112,981 | 116,482 | 89,237 | 100,935 | 88,698 | 88,170 | 78,292 | 79,575 | 76,557 | 80,641 | 72,420 | 66,597 | 69,883 | 78,606 | 61,782 | 62,641 | 62,328 | 58,933 | 53,209 | 56,377 | 62,052 |
LT Debt, Current | - | - | - | - | - | - | - | 3,620 | - | - | - | 4,819 | - | - | - | 3,870 | - | - | - | 1,973 | - | - |
LT Debt, Non Current | -2.3% | 59,268 | 60,657 | 54,513 | 45,438 | 45,799 | 40,796 | 42,383 | 43,345 | 44,348 | 37,420 | 38,648 | 39,895 | 39,901 | 35,779 | 36,808 | 38,507 | 34,473 | 34,419 | 34,581 | 32,053 | 32,096 |
Shareholder's Equity | 1.8% | 87,368 | 85,821 | 81,450 | 78,064 | 76,205 | 76,128 | 75,045 | 73,259 | 72,022 | 69,313 | 68,328 | 68,104 | 66,515 | 59,863 | 60,436 | 57,756 | 55,854 | 54,451 | 54,319 | 52,596 | 50,783 |
Retained Earnings | 1.3% | 89,994 | 88,852 | 86,156 | 83,722 | 80,540 | 78,782 | 77,134 | 75,124 | 73,090 | 71,220 | 69,295 | 69,715 | 67,776 | 62,327 | 61,178 | 58,696 | 56,367 | 55,472 | 55,846 | 54,386 | 52,363 |
Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | - | - | 388 | - | 7.00 | - | - | - | - | - | - |
Accumulated Depreciation | - | - | - | 6,930 | - | - | - | 5,992 | - | - | - | 5,230 | - | - | - | 4,995 | - | - | - | 4,141 | - | - |
Shares Outstanding | -0.5% | 927 | 932 | 934 | 935 | 937 | 941 | 941 | 943 | 944 | 945 | 946 | 950 | 949 | 949 | 948 | 949 | 950 | 958 | 960 | 962 | 961 |
Minority Interest | 11.2% | 5,015 | 4,509 | 3,678 | 3,418 | 3,385 | 3,362 | 3,285 | 2,981 | 3,008 | 2,909 | 2,837 | 2,873 | 2,891 | 2,886 | 2,820 | 2,760 | 2,751 | 2,727 | 2,623 | 2,586 | 2,490 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 11.2% | 41,375 | 37,214 | 26,206 | 33,957 | 22,988 | 21,657 | 22,343 | 25,226 | 20,773 | 25,236 | 22,174 | 22,278 | 22,301 | 18,172 | 18,463 | 14,654 | 12,445 | 10,578 | 15,713 | 10,740 | 17,345 |
Share Based Compensation | 3.7% | 1,025 | 988 | 925 | 884 | 878 | 843 | 800 | 743 | 717 | 704 | 679 | 699 | 687 | 685 | 697 | 651 | 678 | 673 | 638 | 653 | 623 |
Cashflow From Investing | 21.9% | -27,964 | -35,823 | -28,476 | -12,391 | -13,423 | -10,338 | -10,372 | -16,266 | -17,256 | -14,706 | -12,532 | -8,742 | -10,306 | -12,816 | -12,699 | -12,451 | -12,565 | -9,284 | -12,385 | -13,949 | -11,641 |
Cashflow From Financing | -75.5% | 3,707 | 15,112 | 4,226 | -3,793 | -4,774 | -5,938 | -7,455 | -5,424 | -6,045 | -12,106 | -3,590 | -8,206 | -3,244 | 3,950 | -5,625 | -85.00 | -4,509 | -7,059 | -4,365 | -2,677 | -1,842 |
Dividend Payments | - | - | - | 5,991 | - | - | - | 5,280 | - | - | - | 4,584 | - | - | - | 3,932 | - | - | - | 3,320 | - | - |
Buy Backs | 8.1% | 7,027 | 6,500 | 7,000 | 7,050 | 7,100 | 5,850 | 5,000 | 5,659 | 5,459 | 4,209 | 4,250 | 2,940 | 2,690 | 4,189 | 5,500 | 5,951 | 5,851 | 4,852 | 4,500 | 3,977 | 3,605 |
Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Premiums | $ 72,474 | $ 63,896 | $ 145,260 | $ 127,966 |
Investment and other income | 1,115 | 295 | 1,913 | 662 |
Total revenues | 92,903 | 80,332 | 184,834 | 160,481 |
Operating costs: | ||||
Medical costs | 60,268 | 52,093 | 120,113 | 104,616 |
Operating costs | 13,809 | 11,709 | 27,434 | 23,110 |
Cost of products sold | 9,748 | 8,596 | 19,153 | 17,083 |
Depreciation and amortization | 1,021 | 802 | 1,991 | 1,590 |
Total operating costs | 84,846 | 73,200 | 168,691 | 146,399 |
Earnings from operations | 8,057 | 7,132 | 16,143 | 14,082 |
Interest expense | (828) | (467) | (1,582) | (900) |
Earnings before income taxes | 7,229 | 6,665 | 14,561 | 13,182 |
Provision for income taxes | (1,572) | (1,466) | (3,130) | (2,835) |
Net earnings | 5,657 | 5,199 | 11,431 | 10,347 |
Earnings attributable to noncontrolling interests | (183) | (129) | (346) | (250) |
Net earnings attributable to UnitedHealth Group common shareholders | $ 5,474 | $ 5,070 | $ 11,085 | $ 10,097 |
Earnings per share attributable to UnitedHealth Group common shareholders: | ||||
Basic | $ 5.89 | $ 5.41 | $ 11.91 | $ 10.75 |
Diluted | $ 5.82 | $ 5.34 | $ 11.77 | $ 10.61 |
Basic weighted-average number of common shares outstanding | 930 | 937 | 931 | 939 |
Dilutive effect of common share equivalents | 10 | 13 | 11 | 13 |
Diluted weighted-average number of common shares outstanding | 940 | 950 | 942 | 952 |
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 7 | 3 | 6 | 3 |
Products | ||||
Revenue from Products and Services | $ 10,651 | $ 9,496 | $ 20,918 | $ 18,836 |
Services | ||||
Revenue from Products and Services | $ 8,663 | $ 6,645 | $ 16,743 | $ 13,017 |
Condensed Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 41,813 | $ 23,365 |
Short-term investments | 4,466 | 4,546 |
Accounts receivable, net | 17,952 | 17,681 |
Other current receivables, net | 16,131 | 12,769 |
Assets under management | 3,623 | 4,087 |
Prepaid expenses and other current assets | 5,884 | 6,621 |
Total current assets | 89,869 | 69,069 |
Long-term investments | 45,988 | 43,728 |
Property, equipment and capitalized software, net | 10,926 | 10,128 |
Goodwill | 101,669 | 93,352 |
Other intangible assets, net | 15,643 | 14,401 |
Other assets | 16,069 | 15,027 |
Total assets | 280,164 | 245,705 |
Current liabilities: | ||
Medical costs payable | 31,947 | 29,056 |
Accounts payable and accrued liabilities | 29,516 | 27,715 |
Short-term borrowings and current maturities of long-term debt | 6,321 | 3,110 |
Unearned revenues | 14,852 | 3,075 |
Other current liabilities | 30,345 | 26,281 |
Total current liabilities | 112,981 | 89,237 |
Long-term debt, less current maturities | 59,268 | 54,513 |
Deferred income taxes | 2,498 | 2,769 |
Other liabilities | 13,261 | 12,839 |
Total liabilities | 188,008 | 159,358 |
Commitments and contingencies (Note 7) | ||
Redeemable noncontrolling interests | 4,788 | 4,897 |
Equity: | ||
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding | 0 | 0 |
Common stock, $0.01 par value - 3,000 shares authorized; 927 and 934 issued and outstanding | 9 | 9 |
Retained earnings | 89,994 | 86,156 |
Accumulated other comprehensive loss | (7,650) | (8,393) |
Nonredeemable noncontrolling interests | 5,015 | 3,678 |
Total equity | 87,368 | 81,450 |
Total liabilities, redeemable noncontrolling interests and equity | $ 280,164 | $ 245,705 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10 | 10 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 3,000 | 3,000 |
Common stock, shares issued | 927 | 934 |
Common stock, shares outstanding | 927 | 934 |